Latin America Anticoccidial Drugs Market - By Drug Type (Antibiotic Anticoccidials, Ionophore Anticoccidials, Chemical Derivative Anticoccidials), By Animals (Poultry, Swine, Fish, Cattle & Companion Animals.), By Country (Brazil, Mexico, Argentina & Rest of Latin America) - Industry Analysis From 2026 to 2034
The Latin America anticoccidial drugs market size was valued at USD 96.73 million in 2025 and is anticipated to reach USD 100.71 million in 2026 from USD 139.00 million by 2034, growing at a CAGR of 4.11%. during the forecast period from 2026 to 2034.
The ban on consumption of antibiotics as a source of animal feed and the upsurge in incidences of antibiotic resistance microbes has seen reduced growth in the antibiotic market, nevertheless the rising incidence of coccidiosis over the preceding 50 years and its control on the overall cost to benefit ratio for the meat industry has furthered the anticoccidials drug market.
Coccidiosis infects a wide range of animals, such as cattle, poultry species, pigs and sheep which is responsible for the downfall in meat production. Further, an increase in consumer awareness for a healthy diet containing meat proteins is causing a demand for meat production. This has created a need for the adoption of antibiotics (Anticoccidial drugs) by farmers to meet the growing demand for meat production. Besides, less stringent regulations and increased expenditure on companion animals are also assistants in the growth of Latin America anticoccidial drugs market. Further, the trend of owning companion animals is causative to the growing usage of anticoccidials in developing regions.
The Latin America anticoccidial drugs market is classified based on various types of animals and by type of drugs. The animal segment is sub-categorized into poultry, swine, fish, cattle and companion animals. The companion animal segment is divided into dogs and cats. In addition to this, the market is segmented under antibiotic anticoccidials, Ionophore anticoccidials, and chemical derivative anticoccidials. Furthermore, on the basis of geography, the Latin America Market is analyzed under various regions namely, Argentina, Brazil, and Mexico.
The anticoccidial market is facing diverse challenges in form of microbial resistance build-up to antibiotics and stringent government regulations in developed nations, consequently forcing the major players to look for leniently regulated markets in the Latin American regions. These were the regions estimated to grow the most during the forecasted period.
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| CAGR | 4.11% |
| Segments Covered | By Drug Type, Animal Type and Region. |
| Various Analyses Covered | Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Country Covered | Brazil, Mexico, Argentina, Chile, and the Rest of Latin America. |
| Market Leaders Profiled | Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Virbac, Ceva Santé Animale, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare, and Smartvet Inc. |
Some of the key players operating in the Latin America Anticoccidial Drugs Market include
This research report on the Latin America Anticoccidial Drugs Market has been segmented and sub-segmented based on the drug type, animal type, and region.
By Drug Type
By Animal Type
By Country
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region